Evidence map›Paper›PMID 23052709›Full record

ArticleGenes and immunity2012

Age-dependent variation of genotypes in MHC II transactivator gene (CIITA) in controls and association to type 1 diabetes.

A Gyllenberg, S Asad, F Piehl, M Swanberg, L Padyukov, B Van Yserloo, E A Rutledge, B McNeney, J Graham, M Orho-Melander and 20 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  3. Review
  4. Article
  5. Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  6. NOD-like receptors in autoimmune diseases.Acta pharmacologica Sinica · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 10 institutions in 3 countries.

A GyllenbergNeuroimmunology Unit, Department of Clinical Neuroscience, Centre for Molecular Medicine, L8:05, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. alexandra.gyllenberg@ki.se
S Asad
F Piehl
M Swanberg
L Padyukov
B Van Yserloo
E A Rutledge
B McNeney
J Graham
M Orho-Melander
E Lindholm
C Graff
C Forsell
K Akesson
M Landin-Olsson
A Carlsson
G Forsander
S A Ivarsson
H Larsson
B Lindblad
J Ludvigsson
C Marcus
A Lernmark
L Alfredsson
K Akesson
T Olsson
I Kockum
Swedish Childhood Diabetes Study Group
Diabetes Incidence in Sweden Study Group
Better Diabetes Diagnosis Study group
Karolinska University Hospital · SESkåne University Hospital · SEKarolinska Institutet · SELund University · SESimon Fraser University · CAUniversity of Washington · USBoston Children's Hospital · USLinköping University · SESalish Kootenai College · USUniversity of Gothenburg · SE

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
NIDDK NIH HHS DK-17047
6 · The paper itself

Abstract

The major histocompatibility complex class II transactivator (CIITA) gene (16p13) has been reported to associate with susceptibility to multiple sclerosis, rheumatoid arthritis and myocardial infarction, recently also to celiac disease at genome-wide level. However, attempts to replicate association have been inconclusive. Previously, we have observed linkage to the CIITA region in Scandinavian type 1 diabetes (T1D) families. Here we analyze five Swedish T1D cohorts and a combined control material from previous studies of CIITA. We investigate how the genotype distribution within the CIITA gene varies depending on age, and the association to T1D. Unexpectedly, we find a significant difference in the genotype distribution for markers in CIITA (rs11074932, P=4 × 10(-5) and rs3087456, P=0.05) with respect to age, in the collected control material. This observation is replicated in an independent cohort material of about 2000 individuals (P=0.006, P=0.007). We also detect association to T1D for both markers, rs11074932 (P=0.004) and rs3087456 (P=0.001), after adjusting for age at sampling. The association remains independent of the adjacent T1D risk gene CLEC16A. Our results indicate an age-dependent variation in CIITA allele frequencies, a finding of relevance for the contrasting outcomes of previously published association studies.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideWhite PeopleAdolescentAdultAge FactorsAllelesCase-Control StudiesChildChild, PreschoolDiabetes Mellitus, Type 1FemaleGene FrequencyHumansInfantInfant, NewbornCLEC16A protein, humanLectins, C-TypeMHC class II transactivator proteinMonosaccharide Transport ProteinsNuclear ProteinsTrans-Activators

Identifiers

PMID23052709
OpenAlexW2093069194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.